Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on July 28, 2026

31 minutes ago

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Indeterminate GlobeNewswire

34 minutes ago

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Indeterminate GlobeNewswire

36 minutes ago

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance

Indeterminate GlobeNewswire

an hour ago

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

Indeterminate GlobeNewswire

an hour ago

Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth

Indeterminate GlobeNewswire

an hour ago

Trevi Therapeutics to Participate in Upcoming August Conferences

Indeterminate GlobeNewswire

an hour ago

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Indeterminate GlobeNewswire

an hour ago

Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference

Indeterminate GlobeNewswire

an hour ago

Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Indeterminate GlobeNewswire

an hour ago

3D Systems Enables First FDA Clearance for Implant from a Point-of-Care Institution

Indeterminate GlobeNewswire

an hour ago

Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

an hour ago

ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform

Indeterminate GlobeNewswire

an hour ago

Lifecore Biomedical Signs Three New Customer Agreements

Indeterminate GlobeNewswire

an hour ago

Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687

Indeterminate GlobeNewswire

an hour ago

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Indeterminate GlobeNewswire

an hour ago

Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026

Indeterminate GlobeNewswire

an hour ago

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

Indeterminate GlobeNewswire

an hour ago

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Indeterminate GlobeNewswire

an hour ago

Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

Indeterminate GlobeNewswire

an hour ago

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Indeterminate GlobeNewswire